deltatrials
Completed PHASE3 NCT00003421

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease

Sponsor: Medical Research Council

Conditions Lymphoma
Interventions ABVD regimen bleomycin sulfate chlorambucil dacarbazine doxorubicin hydrochloride etoposide prednisolone procarbazine hydrochloride radiation therapy vinblastine sulfate vincristine sulfate
Updated 5 times since 2017 Last updated: Dec 3, 2013 Started: Jun 30, 1998 Completion: Nov 30, 2005

A PHASE3 clinical study on Lymphoma, this trial is completed. The trial is conducted by Medical Research Council and has accumulated 5 data snapshots since 1998. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jun 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical Research Council
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Leeds, United Kingdom
  • • Sheffield, United Kingdom